195 related articles for article (PubMed ID: 12556556)
1. Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.
Atlas E; Cardillo M; Mehmi I; Zahedkargaran H; Tang C; Lupu R
Mol Cancer Res; 2003 Jan; 1(3):165-75. PubMed ID: 12556556
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
[TBL] [Abstract][Full Text] [Related]
3. Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer.
Tsai MS; Shamon-Taylor LA; Mehmi I; Tang CK; Lupu R
Oncogene; 2003 Feb; 22(5):761-8. PubMed ID: 12569369
[TBL] [Abstract][Full Text] [Related]
4. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis.
Weinstein EJ; Leder P
Cancer Res; 2000 Jul; 60(14):3856-61. PubMed ID: 10919660
[TBL] [Abstract][Full Text] [Related]
5. Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors.
Schmitt M; Walker MP; Richards RG; Bocchinfuso WP; Fukuda T; Medina D; Kittrell FS; Korach KS; DiAugustine RP
Mol Carcinog; 2006 Jul; 45(7):490-505. PubMed ID: 16482517
[TBL] [Abstract][Full Text] [Related]
6. Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors.
Barnes CJ; Li F; Mandal M; Yang Z; Sahin AA; Kumar R
Cancer Res; 2002 Mar; 62(5):1251-5. PubMed ID: 11888885
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional up-regulation of paxillin expression by heregulin in human breast cancer cells.
Vadlamudi R; Adam L; Tseng B; Costa L; Kumar R
Cancer Res; 1999 Jun; 59(12):2843-6. PubMed ID: 10383144
[TBL] [Abstract][Full Text] [Related]
8. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV
Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237
[TBL] [Abstract][Full Text] [Related]
9. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.
Menendez JA; Mehmi I; Lupu R
Int J Oncol; 2005 Mar; 26(3):649-59. PubMed ID: 15703820
[TBL] [Abstract][Full Text] [Related]
10. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification.
Ram TG; Schelling ME; Hosick HL
Cell Growth Differ; 2000 Mar; 11(3):173-83. PubMed ID: 10768865
[TBL] [Abstract][Full Text] [Related]
11. A deletion mutant of heregulin increases the sensitivity of breast cancer cells to chemotherapy without promoting tumorigenicity.
Atlas E; Bojanowski K; Mehmi I; Lupu R
Oncogene; 2003 May; 22(22):3441-51. PubMed ID: 12776196
[TBL] [Abstract][Full Text] [Related]
12. Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER-2.
Jhabvala-Romero F; Evans A; Guo S; Denton M; Clinton GM
Oncogene; 2003 Nov; 22(50):8178-86. PubMed ID: 14603258
[TBL] [Abstract][Full Text] [Related]
13. Heregulin regulation of autocrine motility factor expression in human tumor cells.
Talukder AH; Adam L; Raz A; Kumar R
Cancer Res; 2000 Jan; 60(2):474-80. PubMed ID: 10667603
[TBL] [Abstract][Full Text] [Related]
14. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
15. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
[TBL] [Abstract][Full Text] [Related]
16. Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.
Aguilar Z; Akita RW; Finn RS; Ramos BL; Pegram MD; Kabbinavar FF; Pietras RJ; Pisacane P; Sliwkowski MX; Slamon DJ
Oncogene; 1999 Oct; 18(44):6050-62. PubMed ID: 10557094
[TBL] [Abstract][Full Text] [Related]
17. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
[TBL] [Abstract][Full Text] [Related]
18. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.
Lin CQ; Singh J; Murata K; Itahana Y; Parrinello S; Liang SH; Gillett CE; Campisi J; Desprez PY
Cancer Res; 2000 Mar; 60(5):1332-40. PubMed ID: 10728695
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells.
Kim ES; Kim MS; Moon A
Int J Oncol; 2004 Nov; 25(5):1375-82. PubMed ID: 15492828
[TBL] [Abstract][Full Text] [Related]
20. Heregulin up-regulates heat shock protein-70 expression in breast cancer cells.
Mandal M; Li F; Kumar R
Anticancer Res; 2002; 22(4):1965-9. PubMed ID: 12174871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
